On the recordJuly 28, 2021
H.R. 3, Speaker Pelosi's drug pricing bill is NOT the path forward.
Source
congress.govCathy McMorris Rodgers: “H.R. 3, Speaker Pelosi's drug pricing bill is NOT the path forward.”
Editor's note · Context
Opposing H.R. 3, she argues it hinders innovation for neurological disease treatments.
Share
More from Cathy McMorris Rodgers
May 22, 2023
We will continue to demand transparency and accountability from the administration to guard against Federal waste of funds through poor investments and further dependence on our adversaries.
Jun 21, 2023
This rule is completely a mandate by the Federal Government to tell Americans what they think is best.
Jun 20, 2023
Unfortunately, President Biden's rush-to-green agenda puts China more firmly in control of our energy supply.
Other voices in this conversation
